Patient with implantable cardiac device
Conditions
Interventions
From January 2017 to December 2018, admission patients with implantable cardioverter device required the check the unanticipated setting change before and after admission and check the unanticipated s
Sponsors
Mia university hospital Department of Medical Informatics
SATO Healthcare co. Astarisk co. Technomedica co. YUYAMA co. S&
S Engineering co. Loccioni Group (Italy)
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: All patients within the age limit
Exclusion criteria
Exclusion criteria: Only age
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| existence or non-existence of unanticipated setting change of implantable cardiac device | — |
Secondary
| Measure | Time frame |
|---|---|
| existence or non-existence of nursing work alleviation | — |
Countries
Japan
Contacts
Public ContactClinical research ethical review committee Mie university hospital
Mie university hospital Clinical research ethical review committee
Outcome results
None listed